NCT03176953View on ClinicalTrials.gov

Topiramate and Prolonged Exposure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

October 31, 2022

Study Completion Date

September 30, 2023

Conditions
PTSD and Alcohol Use Disorder
Interventions
DRUG

topiramate

active medication

BEHAVIORAL

prolonged exposure

psychotherapy

DRUG

placebo

non-active medication

Trial Locations (1)

92161-0002

VA San Diego Healthcare System, San Diego, CA, San Diego

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

lead

VA Office of Research and Development

FED

NCT03176953 - Topiramate and Prolonged Exposure | Biotech Hunter | Biotech Hunter